Complement fixing antibody to varicella-zoster virus in cancerous patients.
The titer of complement fixing antibody to Varicella-Zoster virus was studied in sera from 161 cancerous patients and 161 healthy controls. Sera with antibody titers greater than or equal to 1/4 were 74 (45.9%) among cancerous patients and 120 (74.5%) among healthy controls. The difference between these two groups is statistically significant.
D000914:Antibodies, Viral / Q000096:biosynthesis*; D001943:Breast Neoplasms / Q000276:immunology; D003168:Complement Fixation Tests; D014645:Herpesvirus 3, Human / Q000276:immunology*; D006689:Hodgkin Disease / Q000276:immunology; D006801:Humans; D008223:Lymphoma / Q000276:immunology; D008545:Melanoma / Q000276:immunology
D000914:Antibodies, Viral